HomeSLS • NASDAQ
add
Sellas Life Sciences Group Inc
Previous close
$5.30
Day range
$4.92 - $5.27
Year range
$0.95 - $6.14
Market cap
888.93M USD
Avg Volume
7.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.16M | -10.76% |
Net income | -7.66M | -13.67% |
Net profit margin | — | — |
Earnings per share | -0.05 | 37.50% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.79M | 417.02% |
Total assets | 78.34M | 303.18% |
Total liabilities | 7.47M | -25.01% |
Total equity | 70.87M | — |
Shares outstanding | 179.58M | — |
Price to book | 11.52 | — |
Return on assets | -27.54% | — |
Return on capital | -30.29% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -7.66M | -13.67% |
Cash from operations | -4.92M | 31.20% |
Cash from investing | — | — |
Cash from financing | 32.39M | 404,825.00% |
Net change in cash | 27.47M | 484.51% |
Free cash flow | -1.56M | 69.59% |
About
Founded
2006
Website
Employees
13
